Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Ormat Technologies
ORA
$5.96B
| $58.1M | 0.05% |
916,557
-7,943
| -0.9% | -$473K |
|
|
FNSR
427
DELISTED
Finisar Corp
FNSR
| $58M | 0.05% |
2,534,500
+1,881,900
| +288% | +$43.1M |
|
428
Universal Corp
UVV
$1.39B
| $57.9M | 0.05% |
953,410
+285,800
| +43% | +$16M |
|
429
Tandem Diabetes Care
TNDM
$1.21B
| $57.9M | 0.05% |
897,927
+123,500
| +16% | +$7.97M |
|
|
AHRT
430
AH Realty Trust
AHRT
$544M
| $57.9M | 0.05% |
3,500,509
+32,400
| +0.9% | +$528K |
|
431
Enterprise Products Partners
EPD
$84.3B
| $57.8M | 0.05% |
2,003,749
-412,200
| -17% | -$11.9M |
|
432
AstraZeneca
AZN
$268B
| $57.8M | 0.05% |
700,319
-221,831
| -24% | -$17.4M |
|
433
ASML
ASML
$602B
| $57.7M | 0.05% |
276,937
+20,588
| +8% | +$4.09M |
|
|
HTO
434
H2O America
HTO
$2.78B
| $57.7M | 0.05% |
949,200
+103,700
| +12% | +$6.38M |
|
|
CKH
435
DELISTED
Seacor Holdings Inc.
CKH
| $57.6M | 0.05% |
1,213,100
+37,100
| +3% | +$1.63M |
|
436
Akamai
AKAM
$16.1B
| $57.6M | 0.05% |
718,600
-31,700
| -4% | -$2.45M |
|
|
PDM
437
Piedmont Realty Trust
PDM
$1.2B
| $57.4M | 0.05% |
2,881,700
-374,800
| -12% | -$7.73M |
|
|
LSI
438
DELISTED
Life Storage, Inc.
LSI
| $57.2M | 0.05% |
902,349
-304,200
| -25% | -$19.5M |
|
439
Steel Dynamics
STLD
$36.9B
| $57.1M | 0.05% |
1,891,700
+1,555,900
| +463% | +$47.6M |
|
440
United Parks & Resorts
PRKS
$2.15B
| $56.6M | 0.05% |
1,825,325
-949,575
| -34% | -$26.1M |
|
441
Amphenol
APH
$175B
| $56.5M | 0.05% |
2,353,600
+1,422,000
| +153% | +$34.2M |
|
442
Nexstar Media Group
NXST
$5.95B
| $56.4M | 0.05% |
558,205
+49,100
| +10% | +$5.27M |
|
|
ACIA
443
DELISTED
Acacia Communications Inc
ACIA
| $56.4M | 0.05% |
1,195,100
+320,600
| +37% | +$16.9M |
|
|
VER
444
DELISTED
VEREIT, Inc.
VER
| $56.2M | 0.05% |
1,248,171
+84,800
| +7% | +$3.67M |
|
|
WAGE
445
DELISTED
WageWorks, Inc.
WAGE
| $56.2M | 0.05% |
1,106,635
+5,100
| +0.5% | +$241K |
|
446
Macerich
MAC
$7.48B
| $56.2M | 0.05% |
1,677,869
+496,600
| +42% | +$19.5M |
|
|
PFPT
447
DELISTED
Proofpoint, Inc.
PFPT
| $55.8M | 0.05% |
463,900
-66,000
| -12% | -$7.77M |
|
|
PTR
448
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $55.7M | 0.05% |
1,012,300
+40,600
| +4% | +$2.43M |
|
|
GOL
449
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $55.7M | 0.05% |
3,297,320
+8,100
| +0.2% | +$107K |
|
450
Essent Group
ESNT
$6.21B
| $55.6M | 0.05% |
1,184,300
-36,200
| -3% | -$1.7M |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.